Ledger.Open graph →

SEC Form D · filed January 5, 2021

CARISMA Therapeutics Inc

Offering

$70.4M

Sold

$38.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

PHILADELPHIA, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven Kelly · Philadelphia, PAExec · Director Regina Hodits · Philadelphia, PADirector Margarita Chavez · Philadelphia, PADirector Jacob Gunterberg · Philadelphia, PADirector Dan Rabinowitz · San Antonio, TXDirector Mike Kienitz · San Antonio, TXExec · Director Tony Padgett · San Antonio, TXDirector Robert Scofield · San Antonio, TXDirector Briggs Morrison · Cambridge, MADirector Michael Heffernan · Cumberland, RIDirector Chidozie Ugwumba · New York, NYDirector Patrick Reilly · Brighton, MAExec · Director Brennen Degner · PLAYA VISTA, CADirector Madhav Krishna · Franklin Lakes, NJDirector Suren Dutia · Franklin Lakes, NJDirector Briggs Morrison · Cambridge, MADirector Michael Heffernan · Canton, MADirector Chidozie Ugwumba · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗